Novartis Kymriah receives EC approval for lymphoma treatment
4th May 2022 Uncategorised 0Approval for Kymriah follows a positive CHMP opinion and is applicable to all 27 EU member states
More: Novartis Kymriah receives EC approval for lymphoma treatment
Source: News
